Treatment of diabetes in patients with inadequate glycemic control despite metformin therapy comprising a DPP-IV inhibitor

Details for Australian Patent Application No. 2010204331 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Dugi, Klaus

Agent Spruson & Ferguson

Pub. Number AU-A-2010204331

PCT Pub. Number WO2010/079197

Priority 09150159.3 07.01.09 EP

Filing date 7 January 2010

Wipo publication date 15 July 2010

International Classifications

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/522 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

9 June 2011 PCT application entered the National Phase

  PCT publication WO2010/079197 Priority application(s): WO2010/079197

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010204340-Article of clothing

2010204327-Excavating device for excavating ground under water, and method for excavating ground